Normal view MARC view ISBD view

Natural aquatic insect carriers of Macrobrachium rosenbergii nodavirus (MrNV) and extra small virus (XSV). [electronic resource]

By:

Sudhakaran, R

Contributor(s):

Producer: 20080807Description: 141-5 p. digitalISSN:

0177-5103

Subject(s):

Online resources:

Available from publisher's website

In: Diseases of aquatic organisms vol. 79

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

There are no comments on this title.

to post a comment.

Back to results

361 Assessment of male sexual function.
by Lukacs, B
362 Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone.
by Erbersdobler, A
363 Androgen deprivation in men with prostate cancer is associated with an increased rate of bone loss.
by Preston, D M
364 Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
by Ebara, S
365 Gene delivery into prostate cancer cells by holmium laser application.
by Sagi, S
366 Pentosan polysulfate decreases prostate smooth muscle proliferation and extracellular matrix turnover.
by Elliot, S J
367 Randomised crossover trial to assess the tolerability of LHRH analogue administration.
by Williams, G
368 Prostate cancer: the right treatment for the right patient. Amsterdam, 17-18 January 2001.
by De Reijke, T M
369 Changes in prostate-specific antigen and hormone levels following withdrawal of prolonged androgen ablation for prostate cancer.
by Egawa, S
370 Transrectal periprostatic lidocaine injection anesthesia for transrectal prostate biopsy: a prospective study.
by Ozveri, H
371 Improved urinary continence after radical retropubic prostatectomy with preparation of a long, partially intraprostatic portion of the membraneous urethra: an analysis of 1013 consecutive cases.
by van Randenborgh, H
372 Reduction of QM protein expression correlates with tumor grade in prostatic adenocarcinoma.
by Altinok, G
373 Bone mineral density changes on androgen deprivation therapy for prostate cancer and response to antiresorptive therapy.
by Yaturu, S
374 Intermittent androgen replacement for intense hypogonadism symptoms in castrated patients.
by Ferreira, U
375 Genome-wide screening for genetic changes in a matched pair of benign and prostate cancer cell lines using array CGH.
by Brookman-Amissah, N
376 What is the best postoperative treatment for patients with pT3bN0M0 adenocarcinoma of the prostate?
by Kasibhatla, M
377 Phase II study of oral capecitabine in patients with hormone-refractory prostate cancer.
by Spicer, J
378 Targeting epitopes in prostate-specific membrane antigen for antibody therapy of prostate cancer.
by Kinoshita, Y
379 Antitumor effect of antisense ODC adenovirus on human prostate cancer cells.
by Zhang, Y
380 Prostate cancer and consistency of reporting sexual histories in men over age 50.
by Dennis, L K